Effects of oral Dexmedetomidine on incidence of anxiety and emergence delirium in surgical and non-surgical anesthesia in preschool children

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202208892145772

Enrollment

180

Registered

2022-08-08

Start date

2021-10-10

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

oral dexmedetomidine drug

no drug used plain apple juice 5 ml

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Children of preschool age (2-6 years old) - ASA I- II children - Children undergoing tonsillectomy operation with or without adenectomy. - Expected duration of the procedure is less than 90 minutes - Children undergoing MRI imaging

Exclusion criteria

Exclusion criteria: • Cardiovascular, renal, respiratory, hepatic or neurological disease. • Behavioral, mental or developmental abnormality (example: mental retardation, Attention Deficit Hyperactivity Disorder “ADHD”, Autism) • Regular intake of either CNS stimulant or depressive drugs (example: Methylphenidate, amphetamine–dextroamphetamine and diazepam respectively) • Parent’s refusal • Emergency case • Allergy to any of the used drugs

Design outcomes

Primary

Measure	Time frame
To evaluate the incidence of occurrence of preprocedural anxiety and postprocedural emergence delirium among surgical and non-surgical procedures. Will oral Dexmedetomidine reduce their occurrence?	—

Secondary

Measure	Time frame
Effect of oral Dexmedetomidine on severity of emergence delirium and pain management	—

Countries

Egypt

Contacts

Public ContactHany ElZahaby

Professor at Anesthesia Department Faculty of Medicine Ain Shams University

hanyzahaby@hotmail.com+201227463000

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026